| Breast Cancer |
1 |
1 |
| Genomic Medicine |
0 |
0.99 |
| Breast Cancer Family History |
0 |
0.73 |
| Cancer |
0 |
0.73 |
| Breast Cancer History |
0 |
0.72 |
| Advanced and Metastatic Breast Cancer |
0 |
0.7 |
| Ovarian Cancer |
0 |
0.62 |
| Pancreatic Cancer |
0 |
0.55 |
| Cancer Risk |
0 |
0.53 |
| Breast |
0 |
0.49 |
| Genetic Testing |
0 |
0.98 |
| Genetics |
0 |
0.41 |
| Mastectomy |
0 |
0.1 |
| BRCA |
0 |
0.07 |
| Clinical Guidelines |
0 |
0.07 |
| Preventive Screening |
0 |
0.03 |
| Surgery |
0 |
0.03 |
| Tumor |
0 |
0.03 |
| Anxiety |
0 |
0.02 |
| Anxiety Disorder |
0 |
0.02 |
| Board Certification |
0 |
0.02 |
| Georgia |
0 |
0.02 |
| Health Care Inequities |
0 |
0.02 |
| Michigan |
0 |
0.02 |
| New York |
0 |
0.02 |
| Nonprofit Organizations |
0 |
0.02 |
| Poly ADP-Ribose Polymerase (PARP) Inhibitor |
0 |
0.02 |
| Social Determinants of Health |
0 |
0.02 |